Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 112,250 | 113,335 | 118,904 | 102,100 | 116,176 |
| Cost of Goods | 46,179 | 52,516 | 51,252 | 44,059 | 51,854 |
| Gross Profit | 66,071 | 60,819 | 67,652 | 58,041 | 64,322 |
| Operating Expenses | 64,356 | 68,268 | 65,838 | 57,879 | 64,799 |
| Operating Income | 1,894 | -6,933 | 2,066 | 221 | 377 |
| Interest Expense | 3,591 | 2,548 | 1,540 | 4,831 | 5,410 |
| Other Income | -859 | 302 | -666 | -2,682 | -469 |
| Pre-tax Income | -2,556 | -9,179 | -140 | -7,292 | -5,502 |
| Income Tax | 859 | 337 | 148 | 518 | -815 |
| Net Income Continuous | -3,415 | -9,516 | -288 | -7,810 | -4,687 |
| Net Income | $-3,415 | $-9,516 | $-288 | $-7,810 | $-4,687 |
| EPS Basic Total Ops | -0.08 | -0.23 | -0.01 | -0.20 | -0.12 |
| EPS Basic Continuous Ops | -0.08 | -0.23 | -0.01 | -0.20 | -0.12 |
| EPS Diluted Total Ops | -0.08 | -0.23 | -0.01 | -0.20 | -0.12 |
| EPS Diluted Continuous Ops | -0.08 | -0.23 | -0.01 | -0.20 | -0.12 |
| EPS Diluted Before Non-Recurring Items | 0.06 | 0.03 | 0.18 | 0.07 | 0.12 |
| EBITDA(a) | $9,172 | $922 | $9,967 | $9,033 | $8,495 |